Rule 1: If a molecule contains a functional group known to cause adverse effects on the blood and lymphatic system, like a sulfonamide group, it is likely to cause adverse effects.
Rule 2: If a molecule contains a functional group known to cause adverse effects on the central nervous system, like a quinolone group, it is likely to cause adverse effects.
Rule 3: If a molecule contains a functional group known to cause adverse effects on the skin, like a benzimidazole group, it is likely to cause adverse effects.
Rule 4: If the molecule contains a phosphate group (P(=O)(O)O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 5: If the molecule contains a chlorine atom (Cl), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 6: If the molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 7: If the molecule contains a benzene ring, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 8: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 9: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 10: If a molecule contains a halogen atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 11: If a molecule contains an arsenic atom or a phosphorus atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 12: If a molecule contains a carboxylic acid, a nitro group, or a chlorine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 13: If a molecule contains an amide group (-C=O-NH-) or a sulfonamide group (-SO2-NH-), it is likely to cause adverse effects related to blood and lymphatic system disorders. If a molecule contains a chlorine atom (Cl) or a fluorine atom (F), it is likely to cause adverse effects related to skin and respiratory system disorders. If a molecule contains a nitro group (-NO2) or a cyano group (-CN), it is likely to cause adverse effects related to central nervous system disorders.
Rule 14: If the molecule has a high molecular weight, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 15: The presence of specific functional groups such as nitro group (-NO2), halogen atom (-Cl, -Br, -I) or carbonyl group (-C=O) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
Rule 16: A molecule containing sulfur-containing functional group or a molecule that can form hydrogen, covalent, ionic, or coordination bonds are more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 17: Molecules containing functional groups such as a carboxylic acid, halogenated aromatic ring, nitro group, sulfur-containing functional group, or a group that can form certain bonds are more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to skin and respiratory system disorders.
Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to central nervous system disorders.
Rule 4: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 5: If a molecule contains a halogen atom (such as chlorine), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 6: The presence of a polar functional group such as an alcohol, amine, or carboxylic acid in a molecule can increase its potential to cause adverse effects.
Rule 7: The presence of a ring structure in a molecule can increase its potential to cause adverse effects.
Rule 8: The presence of a halogen atom such as fluorine, chlorine, bromine, or iodine in a molecule can increase its potential to cause adverse effects.
Rule 9: The presence of a carbonyl group (-C=O) in a molecule is a common structural feature that is associated with adverse effects on the blood and lymphatic system.
Rule 10: The presence of a nitro group (-NO2) in a molecule is also associated with adverse effects on the blood and lymphatic system.
Rule 11: The presence of a halogen atom (-Cl, -Br, -I) in a molecule is associated with adverse effects on the blood and lymphatic system.
Rule 12: If a molecule contains a functional group such as an amide group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 13: If a molecule contains a functional group such as a carboxylic acid group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
Rule 14: The presence of a nitro group (-NO2) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
Rule 15: The presence of a carbonyl group (-C=O) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
Rule 16: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
